{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:43:13Z","timestamp":1790790193593,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00347-022-01732-1","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:22:35Z","timestamp":1665062555000},"page":"1111-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Biomarker in der Therapie ven\u00f6ser retinaler Gef\u00e4\u00dfverschl\u00fcsse","Biomarkers in the treatment of retinal vein occlusion"],"prefix":"10.1007","volume":"119","author":[{"given":"Jakob","family":"Siedlecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Olof","family":"Hattenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried G.","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"1732_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","volume":"117","author":"S Rogers","year":"2010","unstructured":"Rogers\u00a0S et\u00a0al (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117:313\u2013319.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2009.07.017","journal-title":"Ophthalmology"},{"key":"1732_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000502041","volume":"242","author":"U Schmidt-Erfurth","year":"2019","unstructured":"Schmidt-Erfurth\u00a0U et al (2019) Guidelines for the management of retinal vein occlusion by the European society of retina specialists (EURETINA). Ophthalmologica 242:123\u2013162. https:\/\/doi.org\/10.1159\/000502041","journal-title":"Ophthalmologica"},{"key":"1732_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","volume":"248","author":"T Ach","year":"2010","unstructured":"Ach\u00a0T, Hoeh\u00a0AE, Schaal\u00a0KB, Scheuerle\u00a0AF, Dithmar\u00a0S (2010) Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248:155\u2013159. https:\/\/doi.org\/10.1007\/s00417-009-1167-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1732_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ophtha.2008.10.017","volume":"116","author":"IU Scott","year":"2009","unstructured":"Scott\u00a0IU et\u00a0al (2009) SCORE study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 116:504\u2013512. https:\/\/doi.org\/10.1016\/j.ophtha.2008.10.017","journal-title":"Ophthalmology"},{"key":"1732_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/aos.14621","volume":"99","author":"M Michl","year":"2021","unstructured":"Michl\u00a0M et\u00a0al (2021) The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion. Acta Ophthalmol 99:418\u2013426. https:\/\/doi.org\/10.1111\/aos.14621","journal-title":"Acta Ophthalmol"},{"key":"1732_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/eye.2016.57","volume":"30","author":"G Casalino","year":"2016","unstructured":"Casalino\u00a0G, Williams\u00a0M, McAvoy\u00a0C, Bandello\u00a0F, Chakravarthy\u00a0U (2016) Optical coherence tomography angiography in paracentral acute middle maculopathy secondary to central retinal vein occlusion. Eye (Lond) 30:888\u2013893. https:\/\/doi.org\/10.1038\/eye.2016.57","journal-title":"Eye (Lond)"},{"key":"1732_CR7","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1111\/aos.14196","volume":"98","author":"DS Maltsev","year":"2020","unstructured":"Maltsev\u00a0DS, Kulikov\u00a0AN, Burnasheva\u00a0MA, Chhablani\u00a0J (2020) Prevalence of resolved paracentral acute middle maculopathy lesions in fellow eyes of patients with unilateral retinal vein occlusion. Acta Ophthalmol 98:e22\u2013e28. https:\/\/doi.org\/10.1111\/aos.14196","journal-title":"Acta Ophthalmol"},{"key":"1732_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajo.2018.07.031","volume":"195","author":"MF Bakhoum","year":"2018","unstructured":"Bakhoum\u00a0MF et\u00a0al (2018) Paracentral acute middle maculopathy and the ischemic cascade associated with retinal vascular occlusion. Am J Ophthalmol 195:143\u2013153. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.031","journal-title":"Am J Ophthalmol"},{"key":"1732_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/opth.S122683","volume":"11","author":"DJ Browning","year":"2017","unstructured":"Browning\u00a0DJ, Punjabi\u00a0OS, Lee\u00a0C (2017) Assessment of ischemia in acute central retinal vein occlusion from inner retinal reflectivity on spectral domain optical coherence tomography. Clin Ophthalmol 11:71\u201379. https:\/\/doi.org\/10.2147\/opth.S122683","journal-title":"Clin Ophthalmol"},{"key":"1732_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1097\/iae.0000000000001707","volume":"38","author":"S Kitagawa","year":"2018","unstructured":"Kitagawa\u00a0S et\u00a0al (2018) Better prognosis for eyes with preserved foveal depression after Intravitreal ranibizumab injection for macular edema secondary to central retinal vein occlusion. Retina 38:1354\u20131360. https:\/\/doi.org\/10.1097\/iae.0000000000001707","journal-title":"Retina"},{"key":"1732_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/iae.0000000000002444","volume":"40","author":"F Tang","year":"2020","unstructured":"Tang\u00a0F et al (2020) Optical coherence tomography predictors of short-term visual acuity in eyes with macular edema secondary to retinal vein occlusion treated with intravitreal conbercept. Retina 40:773\u2013785. https:\/\/doi.org\/10.1097\/iae.0000000000002444","journal-title":"Retina"},{"key":"1732_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5619","author":"S Gurudas","year":"2022","unstructured":"Gurudas\u00a0S et al (2022) Visual outcomes associated with patterns of macular edema resolution in central retinal vein occlusion treated with anti-vascular endothelial growth factor therapy: a post hoc analysis of the Lucentis, Eylea, Avastin in vein occlusion (LEAVO) trial. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.5619","journal-title":"JAMA Ophthalmol"},{"key":"1732_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.oret.2019.08.009","volume":"4","author":"G Yiu","year":"2020","unstructured":"Yiu\u00a0G et al (2020) Spectral-domain OCT predictors of visual outcomes after ranibizumab treatment for macular edema resulting from retinal vein occlusion. Ophthalmol Retina 4:67\u201376. https:\/\/doi.org\/10.1016\/j.oret.2019.08.009","journal-title":"Ophthalmol Retina"},{"key":"1732_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ophtha.2012.11.011","volume":"120","author":"RB Bhisitkul","year":"2013","unstructured":"Bhisitkul\u00a0RB, Campochiaro\u00a0PA, Shapiro\u00a0H, Rubio\u00a0RG (2013) Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 120:1057\u20131063. https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.011","journal-title":"Ophthalmology"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.oret.2020.12.016","volume":"5","author":"T Etheridge","year":"2021","unstructured":"Etheridge\u00a0T et\u00a0al (2021) Spectral domain OCT predictors of visual acuity in the study of comparative treatments for retinal vein occlusion 2: SCORE 2 report 15. Ophthalmol Retina 5:991\u2013998. https:\/\/doi.org\/10.1016\/j.oret.2020.12.016","journal-title":"Ophthalmol Retina"},{"key":"1732_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6096017","author":"S Fragiotta","year":"2021","unstructured":"Fragiotta\u00a0S et\u00a0al (2021) Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/6096017","journal-title":"J Ophthalmol"},{"key":"1732_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","volume":"116","author":"M Bolz","year":"2009","unstructured":"Bolz\u00a0M et\u00a0al (2009) Optical coherence tomographic hyperreflective foci: a\u00a0morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914\u2013920. https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.039","journal-title":"Ophthalmology"},{"key":"1732_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00417-014-2595-5","volume":"252","author":"JW Kang","year":"2014","unstructured":"Kang\u00a0JW, Lee\u00a0H, Chung\u00a0H, Kim\u00a0HC (2014) Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 252:1413\u20131421. https:\/\/doi.org\/10.1007\/s00417-014-2595-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1732_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.18240\/ijo.2017.04.17","volume":"10","author":"B Mo","year":"2017","unstructured":"Mo\u00a0B, Zhou\u00a0HY, Jiao\u00a0X, Zhang\u00a0F (2017) Evaluation of hyperreflective foci as a\u00a0prognostic factor of visual outcome in retinal vein occlusion. Int J Ophthalmol 10:605\u2013612. https:\/\/doi.org\/10.18240\/ijo.2017.04.17","journal-title":"Int J Ophthalmol"},{"key":"1732_CR20","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1097\/iae.0000000000001070","volume":"36","author":"IP Chatziralli","year":"2016","unstructured":"Chatziralli\u00a0IP, Sergentanis\u00a0TN, Sivaprasad\u00a0S (2016) Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab. Retina 36:2319\u20132328. https:\/\/doi.org\/10.1097\/iae.0000000000001070","journal-title":"Retina"},{"key":"1732_CR21","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1167\/iovs.17-22725","volume":"58","author":"HS Hwang","year":"2017","unstructured":"Hwang\u00a0HS, Chae\u00a0JB, Kim\u00a0JY, Kim\u00a0DY (2017) Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment. Invest Ophthalmol Vis Sci 58:5958\u20135967. https:\/\/doi.org\/10.1167\/iovs.17-22725","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","volume":"132","author":"JK Sun","year":"2014","unstructured":"Sun\u00a0JK et al (2014) Disorganization of the retinal inner layers as a\u00a0predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132:1309\u20131316. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2350","journal-title":"JAMA Ophthalmol"},{"key":"1732_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jamaophthalmol.2018.4484","volume":"137","author":"AS Babiuch","year":"2019","unstructured":"Babiuch\u00a0AS et al (2019) Association of disorganization of retinal inner layers with visual acuity response to anti-vascular endothelial growth factor therapy for macular edema secondary to retinal vein occlusion. JAMA Ophthalmol 137:38\u201346. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.4484","journal-title":"JAMA Ophthalmol"},{"key":"1732_CR24","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s00417-021-05168-2","volume":"259","author":"M Kanai","year":"2021","unstructured":"Kanai\u00a0M et\u00a0al (2021) Association of disorganization of retinal inner layers with optical coherence tomography angiography features in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 259:2897\u20132903. https:\/\/doi.org\/10.1007\/s00417-021-05168-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1732_CR25","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1097\/IAE.0b013e3182899205","volume":"33","author":"YK Chu","year":"2013","unstructured":"Chu\u00a0YK, Hong\u00a0YT, Byeon\u00a0SH, Kwon\u00a0OW (2013) In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a\u00a0\u201cprominent middle limiting membrane sign\u201d. Retina 33:2110\u20132117. https:\/\/doi.org\/10.1097\/IAE.0b013e3182899205","journal-title":"Retina"},{"key":"1732_CR26","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2147\/opth.S260000","volume":"14","author":"O Furashova","year":"2020","unstructured":"Furashova\u00a0O, Matth\u00e8\u00a0E (2020) Hyperreflectivity of inner retinal layers as a\u00a0quantitative parameter of ischemic damage in acute retinal vein occlusion (RVO): an optical coherence tomography study. Clin Ophthalmol 14:2453\u20132462. https:\/\/doi.org\/10.2147\/opth.S260000","journal-title":"Clin Ophthalmol"},{"key":"1732_CR27","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1167\/iovs.18-24153","volume":"59","author":"N Mehta","year":"2018","unstructured":"Mehta\u00a0N et\u00a0al (2018) Increased inner retinal layer reflectivity in eyes with acute CRVO correlates with worse visual outcomes at 12 months. Invest Ophthalmol Vis Sci 59:3503\u20133510. https:\/\/doi.org\/10.1167\/iovs.18-24153","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR28","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/iae.0000000000000054","volume":"34","author":"J Ko","year":"2014","unstructured":"Ko\u00a0J, Kwon\u00a0OW, Byeon\u00a0SH (2014) Optical coherence tomography predicts visual outcome in acute central retinal vein occlusion. Retina 34:1132\u20131141. https:\/\/doi.org\/10.1097\/iae.0000000000000054","journal-title":"Retina"},{"key":"1732_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3928\/23258160-20131101-06","volume":"44","author":"I Tsui","year":"2013","unstructured":"Tsui\u00a0I, Sarraf\u00a0D (2013) Paracentral acute middle maculopathy and acute macular neuroretinopathy. Ophthalmic Surg Lasers Imaging Retina 44:33\u201335. https:\/\/doi.org\/10.3928\/23258160-20131101-06","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"1732_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/icb.0000000000000709","volume":"14","author":"AN Kulikov","year":"2020","unstructured":"Kulikov\u00a0AN, Maltsev\u00a0DS, Leongardt\u00a0TA (2020) Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: a quantitative optical coherence tomography angiography study. Retin Cases Brief Rep 14:343\u2013351. https:\/\/doi.org\/10.1097\/icb.0000000000000709","journal-title":"Retin Cases Brief Rep"},{"key":"1732_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/imcrj.S196047","volume":"12","author":"M Nakamura","year":"2019","unstructured":"Nakamura\u00a0M et al (2019) Longitudinal follow-up of two patients with isolated paracentral acute middle maculopathy. Int Med Case Rep\u00a0J 12:143\u2013149. https:\/\/doi.org\/10.2147\/imcrj.S196047","journal-title":"Int Med Case Rep J"},{"key":"1732_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8867570","author":"Z Zhang","year":"2021","unstructured":"Zhang\u00a0Z, Jiang\u00a0Y, Huang\u00a0X, Wu\u00a0Z, Ke\u00a0B (2021) Clinical characteristics of paracentral acute middle maculopathy in eyes with retinal vascular occlusion diseases in Chinese patients. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/8867570","journal-title":"J Ophthalmol"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"102687","DOI":"10.1016\/j.pdpdt.2021.102687","volume":"37","author":"A Alis","year":"2021","unstructured":"Alis\u00a0A, Guler Alis\u00a0M (2021) The effect of branch retinal vein occlusion on the vascular structure of the choroid. Photodiagnosis Photodyn Ther 37:102687. https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102687","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1732_CR34","doi-asserted-by":"publisher","first-page":"e0258728","DOI":"10.1371\/journal.pone.0258728","volume":"16","author":"BE Hwang","year":"2021","unstructured":"Hwang\u00a0BE, Kim\u00a0M, Park\u00a0YH (2021) Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema. PLoS ONE 16:e258728. https:\/\/doi.org\/10.1371\/journal.pone.0258728","journal-title":"PLoS ONE"},{"key":"1732_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12886-019-1143-9","volume":"19","author":"F Tang","year":"2019","unstructured":"Tang\u00a0F et\u00a0al (2019) Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmol 19:133. https:\/\/doi.org\/10.1186\/s12886-019-1143-9","journal-title":"BMC Ophthalmol"},{"key":"1732_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/bjophthalmol-2018-311898","volume":"103","author":"N Rayess","year":"2019","unstructured":"Rayess\u00a0N et al (2019) Baseline choroidal thickness as a\u00a0short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br J Ophthalmol 103:55\u201359. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-311898","journal-title":"Br J Ophthalmol"},{"key":"1732_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/life11060572","author":"Y Sakanishi","year":"2021","unstructured":"Sakanishi\u00a0Y, Morita\u00a0S, Mashimo\u00a0K, Tamaki\u00a0K, Ebihara\u00a0N (2021) Subfoveal choroidal thickness and treatment outcomes of intravitreal aflibercept for branch retinal vein occlusion. Life (Basel). https:\/\/doi.org\/10.3390\/life11060572","journal-title":"Life (Basel)"},{"key":"1732_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/iae.0000000000001566","volume":"38","author":"M Okamoto","year":"2018","unstructured":"Okamoto\u00a0M, Yamashita\u00a0M, Sakamoto\u00a0T, Ogata\u00a0N (2018) Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion. Retina 38:550\u2013558. https:\/\/doi.org\/10.1097\/iae.0000000000001566","journal-title":"Retina"},{"key":"1732_CR39","doi-asserted-by":"publisher","first-page":"19854","DOI":"10.1038\/s41598-021-99115-0","volume":"11","author":"LF Keidel","year":"2021","unstructured":"Keidel\u00a0LF et al (2021) Pachychoroid disease and its association with retinal vein occlusion: a\u00a0case-control study. Sci Rep 11:19854. https:\/\/doi.org\/10.1038\/s41598-021-99115-0","journal-title":"Sci Rep"},{"key":"1732_CR40","doi-asserted-by":"publisher","first-page":"OCT486","DOI":"10.1167\/iovs.15-18907","volume":"57","author":"M Adhi","year":"2016","unstructured":"Adhi\u00a0M et\u00a0al (2016) Retinal capillary network and foveal avascular zone in eyes with vein occlusion and fellow eyes analyzed with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:OCT486\u2013OCT494. https:\/\/doi.org\/10.1167\/iovs.15-18907","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2015.10.008","volume":"161","author":"F Coscas","year":"2016","unstructured":"Coscas\u00a0F et\u00a0al (2016) Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol 161:160\u2013171.e1\u20132. https:\/\/doi.org\/10.1016\/j.ajo.2015.10.008","journal-title":"Am J Ophthalmol"},{"key":"1732_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-02015-5","author":"L Fan","year":"2021","unstructured":"Fan\u00a0L, Zhu\u00a0Y, Liao\u00a0R (2021) Evaluation of macular microvasculature and foveal avascular zone in patients with retinal vein occlusion using optical coherence tomography angiography. Int Ophthalmol. https:\/\/doi.org\/10.1007\/s10792-021-02015-5","journal-title":"Int Ophthalmol"},{"key":"1732_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1167\/iovs.15-18287","volume":"57","author":"SG Gadde","year":"2016","unstructured":"Gadde\u00a0SG et\u00a0al (2016) Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension. Invest Ophthalmol Vis Sci 57:246\u2013252. https:\/\/doi.org\/10.1167\/iovs.15-18287","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR44","doi-asserted-by":"publisher","first-page":"e0234933","DOI":"10.1371\/journal.pone.0234933","volume":"15","author":"KM Kim","year":"2020","unstructured":"Kim\u00a0KM et\u00a0al (2020) Repeatability of measuring the vessel density in patients with retinal vein occlusion: an optical coherence tomography angiography study. PLoS ONE 15:e234933. https:\/\/doi.org\/10.1371\/journal.pone.0234933","journal-title":"PLoS ONE"},{"key":"1732_CR45","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/iae.0000000000001737","volume":"38","author":"D Seknazi","year":"2018","unstructured":"Seknazi\u00a0D et\u00a0al (2018) Optical coherence tomography angiography in retinal vein occlusion: correlations between macular vascular density, visual acuity, and peripheral nonperfusion area on fluorescein angiography. Retina 38:1562\u20131570. https:\/\/doi.org\/10.1097\/iae.0000000000001737","journal-title":"Retina"},{"key":"1732_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5581319","author":"J Huang","year":"2021","unstructured":"Huang\u00a0J, Lu\u00a0Y, Gu\u00a0X, Zheng\u00a0B, Chen\u00a0T (2021) Correlation between the nonperfusion area on ultra-widefield fluorescein angiography and nonflow area on optical coherence tomographic angiography in retinal vein occlusion. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/5581319","journal-title":"J Ophthalmol"},{"key":"1732_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajo.2020.12.026","volume":"225","author":"G Ryu","year":"2021","unstructured":"Ryu\u00a0G, Park\u00a0D, Lim\u00a0J, van Hemert\u00a0J, Sagong\u00a0M (2021) Macular microvascular changes and their correlation with peripheral nonperfusion in branch retinal vein occlusion. Am J Ophthalmol 225:57\u201368. https:\/\/doi.org\/10.1016\/j.ajo.2020.12.026","journal-title":"Am J Ophthalmol"},{"key":"1732_CR48","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/iae.0000000000002264","volume":"39","author":"L Yeung","year":"2019","unstructured":"Yeung\u00a0L, Wu\u00a0WC, Chuang\u00a0LH, Wang\u00a0NK, Lai\u00a0CC (2019) Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema. Retina 39:1906\u20131916. https:\/\/doi.org\/10.1097\/iae.0000000000002264","journal-title":"Retina"},{"key":"1732_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1167\/iovs.18-26288","volume":"60","author":"YI Shin","year":"2019","unstructured":"Shin\u00a0YI et\u00a0al (2019) Changes in peripapillary microvasculature and retinal thickness in the fellow eyes of patients with unilateral retinal vein occlusion: an OCTA study. Invest Ophthalmol Vis Sci 60:823\u2013829. https:\/\/doi.org\/10.1167\/iovs.18-26288","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR50","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1167\/iovs.16-21208","volume":"58","author":"T Wakabayashi","year":"2017","unstructured":"Wakabayashi\u00a0T et\u00a0al (2017) Retinal microvasculature and visual acuity in eyes with branch retinal vein occlusion: imaging analysis by optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:2087\u20132094. https:\/\/doi.org\/10.1167\/iovs.16-21208","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR51","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1097\/iae.0000000000001828","volume":"38","author":"A Winegarner","year":"2018","unstructured":"Winegarner\u00a0A et\u00a0al (2018) Retinal microvasculature and visual acuity after intravitreal aflibercept in eyes with central retinal vein occlusion: an optical coherence tomography angiography study. Retina 38:2067\u20132072. https:\/\/doi.org\/10.1097\/iae.0000000000001828","journal-title":"Retina"},{"key":"1732_CR52","doi-asserted-by":"publisher","first-page":"OCT242","DOI":"10.1167\/iovs.15-18819","volume":"57","author":"M Casselholmde Salles","year":"2016","unstructured":"Casselholmde Salles\u00a0M, Kvanta\u00a0A, Amr\u00e9n\u00a0U, Epstein\u00a0D (2016) Optical coherence tomography angiography in central retinal vein occlusion: correlation between the foveal avascular zone and visual acuity. Invest Ophthalmol Vis Sci 57:OCT242\u2013OCT246. https:\/\/doi.org\/10.1167\/iovs.15-18819","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR53","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.ophtha.2016.07.008","volume":"123","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam\u00a0C et\u00a0al (2016) Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion. Ophthalmology 123:2352\u20132367. https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.008","journal-title":"Ophthalmology"},{"key":"1732_CR54","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1167\/iovs-16-20648","volume":"57","author":"N Suzuki","year":"2016","unstructured":"Suzuki\u00a0N et\u00a0al (2016) Retinal hemodynamics seen on optical coherence tomography angiography before and after treatment of retinal vein occlusion. Invest Ophthalmol Vis Sci 57:5681\u20135687. https:\/\/doi.org\/10.1167\/iovs-16-20648","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1732_CR55","doi-asserted-by":"publisher","first-page":"737537","DOI":"10.3389\/fmed.2021.737537","volume":"8","author":"Z Zhu","year":"2021","unstructured":"Zhu\u00a0Z et\u00a0al (2021) Microvascular structure changes after Intravitreal ranibizumab injection in retinal vein occlusion patients with and without macular ischemia. Front Med (Lausanne) 8:737537. https:\/\/doi.org\/10.3389\/fmed.2021.737537","journal-title":"Front Med (Lausanne)"},{"key":"1732_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/bjophthalmol-2017-311499","volume":"103","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa\u00a0T, Murakawa\u00a0S, Maruko\u00a0I, Kogure-Katakura\u00a0A, Iida\u00a0T (2019) Correlation between reduction in macular vessel density and frequency of intravitreal ranibizumab for macular oedema in eyes with branch retinal vein occlusion. Br J Ophthalmol 103:72\u201377. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311499","journal-title":"Br J Ophthalmol"},{"key":"1732_CR57","doi-asserted-by":"publisher","first-page":"14153","DOI":"10.1038\/s41598-019-50637-8","volume":"9","author":"KE Choi","year":"2019","unstructured":"Choi\u00a0KE, Yun\u00a0C, Cha\u00a0J, Kim\u00a0SW (2019) OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion. Sci Rep 9:14153. https:\/\/doi.org\/10.1038\/s41598-019-50637-8","journal-title":"Sci Rep"},{"key":"1732_CR58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ophtha.2009.09.019","volume":"117","author":"PS Prasad","year":"2010","unstructured":"Prasad\u00a0PS, Oliver\u00a0SC, Coffee\u00a0RE, Hubschman\u00a0JP, Schwartz\u00a0SD (2010) Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology 117:780\u2013784. https:\/\/doi.org\/10.1016\/j.ophtha.2009.09.019","journal-title":"Ophthalmology"},{"key":"1732_CR59","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1177\/11206721211027411","volume":"31","author":"W An","year":"2021","unstructured":"An\u00a0W, Han\u00a0J (2021) Research progress of UWFFA and OCTA in retinal vein occlusion: a review. Eur J Ophthalmol 31:2850\u20132855. https:\/\/doi.org\/10.1177\/11206721211027411","journal-title":"Eur J Ophthalmol"},{"key":"1732_CR60","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00417-021-05126-y","volume":"259","author":"X Wang","year":"2021","unstructured":"Wang\u00a0X et al (2021) Leakage index on ultra-widefield fluorescence angiography in different regions of retina and its correlation with cystoid macular edema in central retinal vein occlusion eyes. Graefes Arch Clin Exp Ophthalmol 259:2149\u20132156. https:\/\/doi.org\/10.1007\/s00417-021-05126-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1732_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01553-7","author":"L Nicholson","year":"2021","unstructured":"Nicholson\u00a0L et al (2021) The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-021-01553-7","journal-title":"Eye (Lond)"},{"key":"1732_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/IAE.0b013e3181e36c6d","volume":"31","author":"I Tsui","year":"2011","unstructured":"Tsui\u00a0I et\u00a0al (2011) Ischemic index and neovascularization in central retinal vein occlusion. Retina 31:105\u2013110. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e36c6d","journal-title":"Retina"},{"key":"1732_CR63","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/iae.0000000000002126","volume":"39","author":"AS Thomas","year":"2019","unstructured":"Thomas\u00a0AS, Thomas\u00a0MK, Finn\u00a0AP, Fekrat\u00a0S (2019) Use of the ischemic index on widefield fluorescein angiography to characterize a central retinal vein occlusion as ischemic or nonischemic. Retina 39:1033\u20131038. https:\/\/doi.org\/10.1097\/iae.0000000000002126","journal-title":"Retina"},{"key":"1732_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro\u00a0PA et al (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121:209\u2013219. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.038","journal-title":"Ophthalmology"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01732-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01732-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01732-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:13:12Z","timestamp":1668568392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01732-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01732-1","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"assertion":[{"value":"29 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Siedlecki, L.-O.\u00a0Hattenbach, N.\u00a0Feltgen und S.G.\u00a0Priglinger geben an: Keiner der Autoren hat finanzielle Interessen bez\u00fcglich dieser Studie anzumelden. J.\u00a0Siedlecki hat zuvor Vortragshonorare und Reisekostenerstattungen von Novartis Pharma GmbH, Carl Zeiss Meditec AG, Oculentis OSD Medical GmbH, Allergan GmbH, Apellis Pharmaceuticals und Heidelberg Engineering GmbH erhalten. J.\u00a0Siedlecki hat zuvor Beratergeh\u00e4lter von Bayer AG, Novartis Pharma GmbH, Allergan GmbH und Apellis Pharmaceuticals erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}